Planar Laminated Retinal Scaffold for Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating laminated retinoids for retinal tissue engineering are limited by the geometry of spherical retinoid models, which hinder direct contact between photoreceptors and the retinal pigment epithelium, and existing scaffolds fail to support differentiation into laminated retinoids or model therapeutic agent delivery in the vitreous.
Innovation Solution
A scaffold composed of laminin, gelatin, chondroitin sulfate, and hyaluronic acid, sectioned into planar sheets, is used to culture retinal progenitor cells, seeded on top of a monolayer of retinal pigment epithelial cells, to promote differentiation and integration for retinal tissue generation and therapeutic agent testing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If spherical retinoid models are used to generate retinal precursor cells, then retinal differentiation can be modeled, but direct contact between photoreceptors and retinal pigment epithelium is prevented due to geometric constraints
Solution Approach 1:
The invention segments the retinal tissue into distinct planar layers (photoreceptor layer, outer nuclear layer, inner nuclear layer, ganglion cell layer) arranged in a laminated structure. This segmentation allows each layer to contact and interact with adjacent layers, including direct contact between photoreceptors and retinal pigment epithelium, which is prevented in spherical models.
Solution Approach 2:
The invention transitions from a three-dimensional spherical geometry to a two-dimensional planar laminated structure. This dimensional change enables direct lateral contact between photoreceptors and retinal pigment epithelium, facilitating proper tissue integration and signaling that cannot occur in spherical configurations.
2Ease of manufacture
If existing scaffolds are used for retinal tissue engineering, then cell culture is supported, but differentiation into laminated retinoids is not achieved
Solution Approach 1:
The invention employs a composite scaffold material comprising multiple layers with different properties: a porous polymer scaffold for structural support and cell attachment, combined with extracellular matrix proteins (laminin, collagen, fibronectin) for differentiation guidance. This composite structure simultaneously provides mechanical support and molecular cues for precise laminated retinoid differentiation.
Solution Approach 2:
The scaffold is designed with spatially varying properties: the porous polymer provides mechanical strength and porosity for cell infiltration in certain regions, while extracellular matrix proteins are localized to specific interfaces to guide differentiation. This local quality variation enables the scaffold to support both cell culture and precise differentiation into laminated structures.
3Productivity
If spherical retinoid models are used, then retinal precursor cells can be generated, but integration with host neurosensory retina and RPE is prevented
Solution Approach 1:
The planar laminated structure segments the retinal tissue into distinct functional layers that can independently develop and then integrate with host tissue. Each layer maintains its cellular identity while forming continuous interfaces with adjacent layers and host structures, enabling reliable integration that is prevented in spherical models where layers are compressed and isolated.
Solution Approach 2:
By transitioning to a planar two-dimensional architecture, the invention creates extended surface areas for contact between retinal precursor cells and host neurosensory retina and RPE. This dimensional expansion facilitates robust molecular and structural integration that cannot occur in the limited contact surface of spherical models.
4Device complexity
If the small lumen of spherical retinoids is used, then cell containment is achieved, but modeling therapeutic agent delivery into the vitreous is difficult
Solution Approach 1:
The planar laminated structure provides a two-dimensional interface that can be selectively contacted by therapeutic agents delivered into the vitreous. This planar geometry allows modeling of vitreous delivery mechanisms (such as injections or diffusion) while maintaining cell containment, whereas the small spherical lumen limits access and modeling capability.
Data Source
AI summary
The present invention provides a scaffold for culturing retinal tissue comprising an amount of gelatin, an amount of chondroitin sulfate, an amount of hyaluronic acid, wherein the amount of gelatin, chondroitin sulfate, and hyaluronic acid are prepared into a three-dimensional monolith, wherein the monolith is sectioned into planar sheets, and an amount of laminin-521.